Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Totum-63
DIETARY_SUPPLEMENT
2 trials
Sponsors
Valbiotis
Conditions
Disease
Dysglycemia
Hypertriglyceridemia
Insulin Resistance
Obesity
Overweight and Obesity
Prediabetes
Prediabetic State
+1 more
Phase 2
Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes
Completed
NCT02868177
Valbiotis
Disease, Hypertriglyceridemia, Insulin Resistance +3
Start: 2016-10-31
End: 2019-04-30
Updated: 2020-10-05
Unknown Phase
Mode of Action (MoA) Study of TOTUM-63 in Individuals at Increased Cardio-metabolic Risk
Completed
NCT05369585
Valbiotis
Dysglycemia, Overweight and Obesity, Prediabetic State
Start: 2022-04-25
End: 2023-04-12
Updated: 2023-11-13
Related Papers
725-P: TOTUM-63 (T63), a Novel Plant-Based Polyphenol-Rich Substance, Improves Glucose Homeostasis and Modulates Gut Microbiota Diversity among Adults at Increased Cardiometabolic Risk
Diabetes
2024-06-14